BETAPharmaceuticals

BETA Technologies, Inc Class A Common StockQuarterly Results & Earnings

1661.10
+0.00%
Profit Growth YoY-2.13%Latest quarter
Sales Growth YoY12.92%Latest quarter
Sales CAGR 5Y31.89%5 year compound
Profit CAGR 5Y37.14%5 year compound
📋

Quarterly Performance

YoY Profit Growth-2.13%
⚠️ Mild contraction
YoY Sales Growth+12.92%
✅ Strong growth
OPM 5Y Average
Operating profit margin
21.53%
EPS Growth 5Y
37.15%
Interest Coverage
Higher = safer debt servicing
6.03
ROE
25.86%
ROCE
27.04%
💡

Growth Analysis

BETA Technologies, Inc Class A Common Stock reported YoY profit growth of -2.13% and revenue growth of 12.92% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 31.89% and profits at 37.14% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.